Background. Previous associations between surgeon volume with adrenalectomy outcomes examined only a sample of procedures. We performed an analysis of all adrenalectomies performed in New York state to assess the effect of surgeon volume and specialty on clinical outcomes. Methods. Adrenalectomies performed in adults were identified from the New York Statewide Planning and Research Cooperative System from 2000-2014. Surgeon specialty, volume, and patient demographics were assessed. High volume was defined using a significance threshold at ≥4 adrenalectomies per year. Outcome variables included in-hospital mortality, duration of stay, and in-hospital complications. Results. A total of 6,054 adrenalectomies were included. Median patient age was 56 years; 41.9% were men and 68.3% were white. Urologists (n = 462) performed 46.8% of adrenalectomies, general surgeons (n = 599) performed 35.0%, and endocrine surgeons (n = 23) performed 18.1%. Significantly more endocrine surgeons were high-volume compared with urologists and general surgeons (65.2% vs 10.2% and 6.7%, respectively, P < .001). High-volume surgeons had significantly lower mortality compared with lowvolume surgeons (0.56% vs 1.25%, P = .004) and a lower rate of complications (10.2% vs 16.4%, P = < .001). Endocrine surgeons were more likely to perform laparoscopic procedures (34.8% vs 22.4% general surgeons and 27.7% US, P < .001) and had the lowest median hospital duration of stay (2 days vs 4 days general surgeons and 3 days urologists, P < .001). After risk adjustment, low surgeon volume was an independent predictor of inpatient complications (odds ratio = 0.96, P = .002).
The rising prevalence of adrenal incidentalomas and development of minimally invasive surgical techniques has resulted in an increased adrenalectomy rate throughout the past few decades. 2 Although adrenalectomy is associated with an overall low mortality rate (<1%), studies have shown that complication rates can range anywhere from 8% to 20% and mean hospital lengths of stay (LOS) can stretch to upwards of 8 days. 3, 4 These large ranges in complication rate and LOS may in part be due to differences in surgeon volumes. The relationship between surgeon volume and patient outcomes has been examined across a wide variety of procedures including thyroidectomy, pancreaticoduodenectomy, coronary artery bypass grafting, abdominal aortic aneurysm repair, and esophagectomy, and has consistently shown a significant positive association. [5] [6] [7] [8] [9] [10] Prior studies of the relationship between surgeon specialty and patient outcomes for adrenalectomy have demonstrated mixed results likely due to the limitations of the patient databases used in these studies. [11] [12] [13] The state of New York created the Statewide Planning and Research Cooperative System (SPARCS) database, which allows analysis of outcomes from all patients in the state. More importantly, this database contains specific individual surgeon identifiers. Therefore, we aimed to determine whether further characterization of surgical subspecialty in addition to surgeon volume influences patient adrenalectomy outcomes.
Methods

Data source
The New York SPARCS inpatient database was utilized to capture patients undergoing surgery from 2000-2014. SPARCS is a database for the state of New York that captures all patients and payers and collects information on patients, treatments, and providers for every emergency department admission, inpatient admission, hospital discharge, outpatient visit, and ambulatory surgery appointment.
Patient population
Adult patients (≥18 years old) undergoing adrenalectomy were the focus of this analysis. Adrenalectomy procedures were selected based on their International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) procedure code, including partial, unilateral, and bilateral adrenalectomy (ICD-9 codes 07.29, 07.22, 07.3). Patients who underwent adrenalectomy in the setting of trauma, liver transplantation, renal malignancy, or as part of a urologic procedure without a diagnosis of primary adrenal disease were excluded. Patient comorbidities were standardized through calculation of the Charlson Comorbidity Index (CCI). 14 
Surgeon identification and characteristics
Unique surgeon identifiers in SPARCS (NY state physician license number) were utilized to identify surgeons. Surgeon specialty designations were determined as follows: urologists (US) were identified as those surgeons who had performed a prostatectomy, cystectomy, and cystoscopy in a year for ≥2 consecutive years. This narrower definition of identifying urologists in a large dataset was utilized after the method used by Park et al 13 misidentified some general surgeons as urologists. All surgeons in this study population that were registered as active or candidate members in the American Association of Endocrine Surgeons (AAES) database 15 were included in the group of endocrine surgeons (ES). All other surgeons who were not urologists or endocrine surgeons were classified as general surgeons (GS).
Independent variables
Surgeon specialty and surgeon volume were the 2 primary independent variables in this study and were treated as categorical variables. High volume surgeons were defined as those who perform ≥4 adrenalectomies per year as described by Park et al. 13 Adrenalectomies were further categorized as unilateral, bilateral, or partial; and technique was classified as minimally invasive (laparoscopic or robotic) or open. Although there are no specific codes for laparoscopic adrenalectomy, previously published methodology 13 was utilized to combine the code for laparoscopy or robotic-assisted laparoscopy of the abdomen with the code for adrenalectomy to identify these procedures.
Patient demographic variables included age, race, ethnicity, payer status. Hospital level variables included teaching hospital status (i.e., affiliated with a general surgery residency program) and whether the hospital was in New York City.
Outcome variables
The primary outcome variable was in-hospital complication. Complications were categorized as postoperative shock, hemorrhagic, infectious/wound, cardiovascular, respiratory/ventilator-associated complications, enteric fistula/leak, adrenal insufficiency, urinary, and other (including retained foreign body; Appendix A). Secondary outcome variables were LOS and in-hospital mortality.
Statistical analysis
Bivariate analysis of the independent variables with the outcomes of interest were performed using the χ 2 test for categorical variables and analysis of variance for continuous variables. Multivariable logistic regression was utilized for adjusted analysis of complications and mortality. Multivariable linear regression was used for LOS. Data analysis and management were performed using a statistical software program (Stata, version 13.0, StataCorp, College Station, TX). The Institutional Review Board deemed this study exempt from review.
Results
Patient and provider characteristics
Between January 1, 2000, and December 31, 2014, 9,385 adult patients were identified in the SPARCS database as having a procedure code for adrenalectomy. One hundred thirty patients were excluded based on the likelihood that adrenalectomy was performed in the setting of trauma. Four patients were excluded on the likelihood that adrenalectomy was performed in the setting of liver transplantation. Patients were also excluded based on the likelihood that the adrenalectomy was performed as part of a primary urological procedure (n = 3,197).
A total of 6,054 adrenalectomies were included in the analysis. Overall, 671 (11.1%) of patients experienced at least 1 complication after adrenalectomy, and 51 patients died (0.84%). Median LOS was 3 days (interquartile range [IQR] 2-6) with a mean and standard deviation of 5.3 ± 8.6 days. Hemorrhage accounted for 34.1% of all complications, followed by pulmonary (23.5%), cardiac (18.9%), infectious (11.3%), adrenal insufficiency (10.3%), urinary (9.8%), and wound disruption (1.9%) events (see Appendix A for a list of the ICD-9 codes for each complication).
The majority of patients were female, white, insured by a private insurance carrier, underwent adrenalectomy for a benign neoplasm, had a unilateral adrenalectomy, and had an open operation. Most adrenalectomies were performed at teaching hospitals and in NYC. The distribution of patient demographics and other comorbidities is shown in Table I .
There were 2,839 adrenalectomies performed by 462 US (46.9%), 1,098 by 23 ES (18.1%), and 2,117 by 599 GS (35.0%; Table II ). The majority of patients were white and female among all surgeon groups. Endocrine surgeons tended to operate on patients with private insurance, low preoperative comorbidities, and with primary endocrine disorders of the adrenal gland significantly more often than general or urologic surgeons. General surgeons were more likely than ES or US to operate on nonwhite patients, and US also were more likely than GS or ES to operate on patients with high CCI or nonprivate insurance. Endocrine surgeons also operated more frequently at teaching hospitals, in New York City, and used minimally invasive techniques more often.
Surgeon volume
Median annual surgeon volume was 1 case (IQR 1-2) with a mean of 2. A significantly greater number of high volume surgeons practice in teaching hospitals (77.6% vs 22.5%, P < .001) or in New York City (64.4% vs 35.6%, P < .001), irrespective of specialty. Overall, high volume surgeons had a significantly lower complication rate compared to low volume surgeons (8.76% vs 14.42%, P < .001) as well as lower median LOS (high volume: 2 days [IQR 1-5] vs low volume: 4 days [IQR 2-7], P < .001). High volume surgeons also had a significantly lower mortality rate of 0.56% compared with low volume surgeons 1.25% (P = .004).
Unadjusted outcomes
There were several significant differences in unadjusted clinical outcomes by patient (Table III) and provider (Table IV) characteristics. Demographic groups with significantly higher complication rates included older individuals, patients with Medicare, malignant diagnosis, open procedure, and higher comorbidity score. Complications also were more common among US and GS compared with ES (P < .001) and low-volume compared with highvolume surgeons (P < .001). Of the 51 total deaths, ES had the lowest mortality (n = 2, 0.18%) compared with GS (n = 17, 0.80%), and US (32, 1.13%; P = .014).
Older individuals, patients with Medicare, open procedures, a high CCI score, or bilateral adrenalectomy also had a significantly longer LOS. Complications were more common among urologic and general surgeons and low-volume surgeons, and hospital LOS also was significantly longer for these groups. There was no significant difference in complication rates or LOS based on teaching hospital status or location.
Adjusted outcomes
Independent variables with significantly different complication rates on bivariate analyses were included in a multivariable logistic regression to identify independent predictors of complication after adrenalectomy (Table V) . After adjustment, surgeon volume but not specialty, was an independent predictor of complications and mortality. In addition to high surgeon volume, undergoing a minimally invasive operative approach also was associated with significantly lower complication rates. More patient comorbidities, increasing age, and receiving a perioperative transfusion were associated with significantly higher complication rates. For secondary outcome measures, the same predictors of complications after adrenalectomy also predicted hospital LOS with the addition of endocrine surgeons being associated with significantly shorter hospital LOS while patients experiencing complications had a significantly longer hospital LOS (Table VI) . Neither specialty nor annual volume was predictive of inpatient mortality, but presence of a complication was predictive of mortality (odds ratio [OR] 7.38, 95% confidence interval [CI], 4.01-13.59, P < .001). Multivariate logistic regression analysis of independent predictors of complications after adrenalectomy, reported as OR with 95% CI. Multivariate linear regression analysis of independent predictors of hospital LOS after adrenalectomy, reported as β-coefficient with 95% CI.
Discussion
This is the first population-based study of clinical outcomes after adrenalectomy to examine all associated procedures performed within a given state, and the impact of surgeon specialty and duration of practice on patient outcomes after adrenalectomy. The SPARCS database allows for specific surgeon identifiers that more precisely categorize the subset of general surgeons with a subspecialty focus in endocrine surgery, as well as estimating how long each surgeon has been in practice. After adjustments for all other demographic and clinical characteristics captured in the SPARCS database between 2000 and 2014, endocrine surgeons had significantly shorter hospital LOS, but not complication rates compared with general or urologic surgeons. Surgeon volume was an independent predictor of adrenalectomy complications and hospital LOS in this study. While surgeon specialty was not associated directly with adrenalectomy complications in adjusted analyses, endocrine surgeons were significantly more likely to meet the definition of highvolume compared with surgeons from other specialties. Thus, subspecialty practice may be a reasonable surrogate marker for highvolume surgeons.
Prior literature about the association between adrenalectomy outcomes and surgeon volume has shown mixed results. Park et al 13 used data from the HCUP-NIS from 1999-2005 to demonstrate that surgeon volume was associated strongly with in-hospital complications and hospital LOS after adrenalectomy, but surgeon specialty (general surgeons and urologists) was not. Using state-level HCUP-NIS data from New York and Florida, Stavrakis et al 11 found no association between surgeon volume and complications after adrenalectomy, but surgeon volume was associated with hospital LOS. These studies are limited by the fact that the HCUP-NIS provides annual data from only a 20% sample of state databases from around the country. Furthermore, while HCUP-NIS provides unique surgeon identifiers, it does not allow for identification of surgeon specialty and specialty must be inferred from procedure codes available within the dataset itself. In another study, Gallagher et al 12 found no association between surgeon volume and complication rates or hospital LOS using Florida hospital discharge data, but was limited by the relatively smaller size and shorter period of time. By examining outcomes from a database that captures information from all adrenalectomies performed, a more complete picture of clinical outcomes can be formed.
The question of surgeon specialty and its relationship to patient outcomes has been studied extensively, both in the context of adrenalectomy as well as in other operations. For both esophagectomy and lung resections, thoracic surgeons have been shown to have lower operative mortality than other surgeons 16, 17 and vascular surgeons have lower in-hospital mortality following carotid endarterectomy than either neurosurgeons or general surgeons. 18 For adrenalectomy, general surgeons did have lower complication rates compared with urologists on unadjusted analysis in the study by Park et al, 13 but only the relationship between surgeon volume and outcomes remained significant following risk adjustment. No previously reported study has looked specifically at outcomes of adrenalectomy performed by endocrine surgeons in a large database. This study specifically identified endocrine surgeons through membership in AAES, allowing for a detailed analysis of endocrine surgeon outcomes for adrenalectomy. While surgical subspecialty was not shown to be an independent predictor of complications after adrenalectomy, it was significantly associated with hospital LOS. Data from this study also have shown that surgical subspecialty is closely tied to surgeon volume in that endocrine surgeons were more likely than general or urologic surgeons to meet the definition of high volume. Additionally, because such surgical subspecialization is a more recent trend, this study may be underpowered to detect a difference given that the overall proportion of adrenalectomies performed by endocrine surgeons was less than those from general and urologic surgeons, and further study is warranted in this area.
The finding that endocrine surgeons are more likely than surgeons from other disciplines to meet criteria for high-volume adrenalectomy surgeons has broad and important implications. First is the impact on regional hospital specialization and patient referral patterns. Similar to the Centers of Excellence that have been developed in bariatrics and other fields, 19 continued expansion of regional health systems may lead to clustering of operative services at a fewer number of healthcare facilities. While some authors have advocated this approach as part of a "volume pledge," other have argued that this may paradoxically limit access to care and create further socioeconomic disparities between those that do and do not have resources to travel for high-volume care. [20] [21] [22] Our findings are also informative for shaping the future of surgical training. Adrenalectomy is listed as an "advanced" procedure in the ACS/ ABS/APDS SCORE Curriculum 23 and one study of general surgery resident case logs demonstrates an average of only ≈2 adrenalectomies per resident. 24 Endocrine surgery fellows complete their training with an average of 13 adrenalectomies, 25 so efforts to expand the job market for these potentially high-volume adrenal surgeons is one method of ensuring patient access to quality care. 26 Limitations of this study include those inherent to any large administrative database (coding errors, incomplete data capture, etc.), although SPARCS captures all procedures performed within the state of New York and thus represents a very complete picture of what occurs within one geographic area. However, these results may or may not be generalizable to other populations. SPARCS contains surgeon identifiers (state medical license number) that were matched with the membership list of the AAES. It is possible that not all urologists, general surgeons, and endocrine surgeons were matched into their specialty accurately. This study also was not able to adequately capture the true rate of minimally invasive approaches to adrenalectomy performed in New York State during the study period, largely due to the inability to specifically code for retroperitoneoscopic adrenalectomy. While some of these procedures may have been included in the "laparoscopic" procedure category, the majority were coded as open procedures, incongruous with the practice patterns of many of the identified, highvolume adrenal surgeons in this sample. Interestingly, the use of a minimally invasive approach was associated with a decreased rate of complications on adjusted analysis. This finding demonstrates how significant the reduction in complications is for minimally invasive techniques. Although likely underreported, the rate of minimally invasive adrenalectomy is similar to that reported in other studies of adrenalectomy outcomes 27 and also is consistent with the trend toward increasing use of laparoscopy over the study period. In addition, both high-volume surgeons and endocrine surgeons used laparoscopy more frequently than did low-volume surgeons and urologic or general surgeons, and laparoscopy was found to be an independent predictor of lower complication rates. Finally, observed complication rates may be underestimated because this study only examined outcomes in the index hospital admission and complications such as wound infection were commonly diagnosed after discharge.
In conclusion, surgeon volume was an independent predictor of complications and mortality after adrenalectomy. Subspecialty endocrine surgeons were significantly more likely to meet the definition of high-volume compared with general surgeons or urologists. While patients with adrenal disease should be referred to surgeons based on their annual volume of adrenalectomies, sub-specialty practice may be a reasonable surrogate marker for high-volume surgeons. This finding has important implications for regional hospital specialization, patient referral patterns, and surgical training.
Dr Dimitrios A. Linos (Athens, Greece): Congratulations for this revealing data, but I was kind of surprised with 2 things. Firstly, this definition of a busy, high volume surgeon of >4 cases or even 6 per year, do you think it is appropriate, should it be corrected? And, secondly, the data that you showed that the endocrine surgeons use the endoscopic laparoscopic approach in only 30% of the cases.
Dr Brenessa M. Lindeman: Thank you very much for your questions.
I will answer the second question first, which was regarding the low rate of minimally invasive techniques in our study. And this has to do with inadequate capture of retroperitoneoscopic adrenalectomy. The database uses ICD-9 procedure codes, and there is not one for a posterior retroperitoneal approach.
There was one case in the entire database that was coded as also being performed minimally invasive plus a retroperitoneoscopic dissection. And being able to identify surgeons individually, we know that the endocrine surgeons in this dataset perform a lot of these approaches. And so they got lumped into outcomes for patients that look like it is an open adrenalectomy. And so I think that speaks to the fact that the minimally invasive technique was a predictor of lower rates of complications following adrenalectomy, and I think that speaks to the fact that any minimally invasive approach is superior to any open approach.
Regarding your first question about the definition of high volume, it was the intention of our study to assess the impact of surgeon subspecialty using a more granular definition, being able to pull out endocrine surgeons. And so we wanted to be very consistent with previously published literature in that regard. I think that really finding a true definition of high volume for a specialty is a very complex question. And I know you mentioned the next paper up on our program may do an excellent job of reviewing that for us.
Dr Jennifer Rosen (Washington, DC): Thank you very much for a very timely presentation. As much as many of us would love to be high volume adrenal surgeons, I think we see this often comes up in discussion about what the best combination is. So, was there an attempt made or could you from your data look at whether or not those procedures were performed in combination with other complex abdominal surgery or in the setting of other extensive experience by those particular surgeons you studied looking at minimally invasive approaches? Dr Brenessa M. Lindeman: Thank you very much for your question.
We wanted to isolate procedures as best we could that were adrenalectomies alone, which was why we excluded those in particular performed as part of a urologic procedure. But it becomes very difficult in the dataset to be able to determine the other types of procedures that go along with it, so I do not think we have complete information for me to be able to answer your question fully. That would be a great area for a future study.
Thank you. Dr Quang Yang Duh (San Francisco, CA): Very, very nice study. My question for you is, there is a general problem with using these large databases. If you ask the surgeons here, in your experience what will predict complications or longer hospital stay, the 2 things that usually stand out are the kind of disease that the patient has, it is a pheo, it is a very bad Cushing's, et cetera, and the size of the tumor. It is a 10-cm tumor. It is a 1-cm aldosteronoma.
The question I have for you is, do you have any way to capture that kind of information in these large databases, because otherwise that variable, the size and the disease could overwhelm anything else that you can think about?
Dr Brenessa M. Lindeman: Absolutely. Thank you so much. We have no way to determine tumor size within this database, however, we were able to have slightly more granular information about patient diagnosis, including pheochromocytoma or other endocrine disorders. And there were actually no significant differences for complications or hospital length of stay by diagnosis, which is why in terms of the presentation, I lumped them together with other benign nonfunctional adrenal diseases.
Dr Richard A. Prinz (Evanston, IL): So New York is a wonderful state, of course, but its demographics are interesting. And you have a large city, but you also have a large rural component in many other smaller communities. So, I presume there are many hospitals in those smaller communities where you have 1 or 2 adrenalectomies being done.
So, have you looked at hospital size as a component of your study. Also, when I go to code for my adrenalectomies, I get the same code whether I am using an open or laparoscopic procedure. So, I am not sure you can really differentiate or get from your database how many are being done this way or the other.
Dr Brenessa M. Lindeman: Thank you very much for your comments. I agree about the limitations with coding. That is always a confounder in these datasets. And I think as far as the hospital volume question, it is a great area for future study that we did not have the bandwidth to examine at this particular time.
Thank you very much.
